MARKET

ZTS

ZTS

Zoetis Inc
NYSE
153.58
+2.23
+1.47%
Opening 14:20 10/04 EDT
OPEN
153.31
PREV CLOSE
151.35
HIGH
155.31
LOW
152.78
VOLUME
838.32K
TURNOVER
63.36M
52 WEEK HIGH
249.27
52 WEEK LOW
147.77
MARKET CAP
71.90B
P/E (TTM)
34.85
1D
5D
1M
3M
1Y
5Y
Buy Disney, sell American Airlines among BofA's top 10 fourth quarter ideas
BofA Securities picked nine longs and one short in its list of best alpha-generating ideas for Q4 out Monday.
Seekingalpha · 1d ago
BRIEF-Zoetis Completes Acquisition Of Jurox
BRIEF-Zoetis Completes Acquisition Of Jurox
Reuters · 4d ago
Zoetis Completes Acquisition of Animal Health Firm Jurox
Zoetis Completes Acquisition of Animal Health Firm Jurox
MT Newswires · 4d ago
Zoetis to Host Webcast and Conference Call on Third Quarter 2022 Financial Results
PARSIPPANY, N.J., September 29, 2022--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 3, 2022. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph w...
Business Wire · 5d ago
Here's Why Zoetis (NYSE:ZTS) Has Caught The Eye Of Investors
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Simply Wall St. · 6d ago
These 2 Stock Giants Are Flirting With a Bottom; Analysts Say ‘Buy’
Anyone following stock market trends in 2022 will be well aware of the widespread drawbacks; apart from some outliers such as energy, most corners of the market have been beaten to a pulp. The main culprits are easily identified by now; a combination of a ...
TipRanks · 6d ago
The Price Is Right For Zoetis Inc. (NYSE:ZTS)
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 13x, you may...
Simply Wall St. · 09/24 11:00
Zoetis CEO on equalizing the work experience for in-office and remote employees
At Zoetis, all employees now have more flexibility than they had going into the pandemic, "deskless" or not.
Fortune · 09/21 22:00
More
About ZTS
Zoetis Inc. is an animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. It commercializes products across eight core species: dogs, cats and horses and cattle, swine, poultry, fish and sheep and within product categories, such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. It operates through two segments: the United States and International. Within each of these operating segments, it offers a product portfolio for both companion animal and livestock customers, including Alfaxan. The Company market its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America, and its products are sold in more than 100 countries.

Webull offers kinds of Zoetis Inc stock information, including NYSE:ZTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZTS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ZTS stock methods without spending real money on the virtual paper trading platform.